ClinicalTrials.gg
Sign In

Tachycardia clinical trials

The registry lists 189 studies for Tachycardia across more than 10 countries. 24 are recruiting or about to start. 76 of them are mainly about Tachycardia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Tachycardia, Ventricular: 687 studies, 153 open.

Get an email when these change. Save the Tachycardia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
113
Recruiting
18
Status unknown
18
Terminated
15
Active, not recruiting
12
Withdrawn
7

Phase

Phase 4
18
Phase 3
11
Phase 2
10
Phase 1
8
Early Phase 1
2

Where

United States
76
Germany
30
Italy
21
United Kingdom
16
France
15
Spain
15

Who runs them

Medtronic Cardiac Rhythm and Heart Failure (16) · Abbott Medical Devices (13) · Biotronik SE & Co. KG (12) · Boston Scientific Corporation (11) · Vanderbilt University Medical Center (6) · AtriCure, Inc. (4) · Medtronic (4) · Vanderbilt University (3)

What is being tested here

Drugs under test in Tachycardia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexmedetomidine114
Phenylephrine103
Ivabradine113
Norepinephrine102
Epinephrine102
Atenolol102
Propofol101
Arginine Vasopressin101
Landiolol111
Adenosine111

Drug classes tested here Beta blockers 2 open · Bronchodilators 1 open

Coming up

3phase 3 studies under way
11studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 18 Tachycardia studies recruiting now, 10 (56%) set no upper age limit and 3 (17%) stop at 75 or younger. 1 (6%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (11%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
101 (6%)1 (6%)
1816 (89%)16 (89%)
3018 (100%)18 (100%)
4018 (100%)18 (100%)
5018 (100%)18 (100%)
6516 (89%)16 (89%)
7515 (83%)15 (83%)
8512 (67%)12 (67%)

Across all 189 studies, recruiting or not: 22% stop at 75 or younger and 17% at 65; 13% take children; 2% are for women only and 1% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Tachycardia studies take

Of 37 interventional studies with no phase under Tachycardia, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase20 mo9–36 · 37 studies——
Observational21 mo14–43 · 27 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 189. Browse all 189 → or search them.